Home > Healthcare > Biotechnology > Biopharma > Protein Engineering Market

Protein Engineering Market Share

Report ID: GMI8008
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Protein Engineering Market Share

These industry players are developing innovative technologies as well as products and are continuously investing in R&D and expanding their portfolios to meet the evolving market demands. They are also indulging in partnership ventures to widen their global presence and customer base.

Protein Engineering Market Companies

Some of the major protein engineering industry players are:

Agilent Technologies, Inc.
Amgen Inc.
Bio-Rad Laboratories, Inc.
Bristol Myers Squibb Company
Bruker Corporation
Danaher Corporation
Genentech, Inc.
Integrated DNA Technologies, Inc.
Lonza Group
Merck KGaA
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals Incorporated

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Protein engineering market size was over USD 2.5 billion in 2023 and is expected to register 15.9% CAGR from 2024-2032 owing to the growing collaborations and partnerships for fostering innovations and advancements in the field, worldwide.

Protein engineering industry from the reagents segment is expected to register 16.2% CAGR from 2024-2032 due to playing a crucial role in protein engineering, with researchers continuously refining and developing new ones.

North America protein engineering industry is expected to reach over USD 3.75 billion by 2032 due to notable shift towards sustainable and green technologies in the region.

Amgen Inc., Bruker Corporation, Danaher Corporation, Genentech, Inc., Integrated DNA Technologies, Inc., Lonza Group, Merck KGaA, Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Incorporated, are some of the major protein engineering companies worldwide.